CBO Finds Safe Step Act Costs $2B As Stakeholders Push Bill For Lame Duck

By Amy Lotven / December 6, 2024 at 6:03 PM

The Safe Step Act, a bipartisan, bicameral bill requiring employer plans to establish a clear exceptions process for medication step therapy, would boost access to prescribed drugs but would likely increase premiums for those plans while reducing federal revenue by $2 billion over a decade, according to Congressional Budget Office score out Thursday (Dec. 5).


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.